Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 NOK)

NET PROFIT (x1000 NOK)

Share

Xellia Pharmaceuticals AS

Closing information (x1000 NOK)

Closing information 2024/12 2023/12 2022/12
Turnover 83,145 More Arrow 85,872 More Arrow 88,993
Financial expenses 3 More Arrow 13 Less Arrow 3
Earnings before taxes 86,236 Less Arrow 50,609 More Arrow 52,097
Total assets 781,317 Less Arrow 732,234 Less Arrow 680,840
Current assets 261,966 Less Arrow 244,001 Less Arrow 213,041
Current liabilities 71,226 Less Arrow 54,428 Less Arrow 18,698
Equity capital 707,205 Less Arrow 674,435 Less Arrow 658,544
- share capital 223,257 Equal arrow 223,257 Equal arrow 223,257

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 90.5% More Arrow 92.1% More Arrow 96.7%
Turnover per employee
Profit as a percentage of turnover 103.7% Less Arrow 58.9% Less Arrow 58.5%
Return on assets (ROA) 11.0% Less Arrow 6.9% More Arrow 7.7%
Current ratio 367.8% More Arrow 448.3% More Arrow 1139.4%
Return on equity (ROE) 12.2% Less Arrow 7.5% More Arrow 7.9%
Change turnover -2,727 Less Arrow -3,121 More Arrow 15,740
Change turnover % -3% Less Arrow -4% More Arrow 21%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.